Graphite Bio Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GRPH Nasdaq 2836 https://graphitebio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Graphite Bio Inc

Sickle-cell gene therapy developer stops program, cuts half of staff - Feb 23rd, 2023 10:36 pm
Graphite Bio Announces Process to Explore Strategic Alternatives and Corporate Restructuring - Feb 22nd, 2023 9:05 pm
Down -39.59% in 4 Weeks, Here's Why Graphite Bio, Inc. (GRPH) Looks Ripe for a Turnaround - Jan 10th, 2023 2:35 pm
Two Covid-era biotech IPOs — Spruce and Graphite Bio — see stock head in different directions - Jan 6th, 2023 10:54 pm
Graphite Bio Shares Tank After Pausing Sickle Cell Therapy Study - Jan 6th, 2023 2:07 pm
Graphite Bio pauses early-stage blood disease therapy trial - Jan 5th, 2023 10:57 pm
Graphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell Disease - Jan 5th, 2023 9:05 pm
Graphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual Meeting - Dec 11th, 2022 3:00 pm
Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference - Nov 21st, 2022 1:00 pm
2 “Strong Buy” Penny Stocks That Could See 200% Gains (Or More) - Nov 17th, 2022 2:45 pm
Graphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial Results - Nov 9th, 2022 9:05 pm
Graphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and Exposition - Nov 3rd, 2022 1:05 pm
Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation - Oct 16th, 2022 12:33 pm
Graphite Bio Announces Participation in 50th Annual Sickle Cell Disease Association of America National Convention - Oct 11th, 2022 12:00 pm
Graphite Bio Announces Participation in Morgan Stanley 20th Annual Global Healthcare Conference - Sep 6th, 2022 12:00 pm
Graphite Bio Reports Recent Business Progress and Second Quarter 2022 Financial Results - Aug 11th, 2022 8:05 pm
Graphite Bio Doses First Patient with Investigational Gene Editing Therapy GPH101 for Sickle Cell Disease - Aug 11th, 2022 12:16 pm
BMO Capital Sees Over 400% Upside For This Small Gene-Editing Stock - Jun 17th, 2022 6:26 pm
Graphite Bio Announces Participation in Jefferies Healthcare Conference - Jun 1st, 2022 12:00 pm
I'm 'Following Up' on a Biotech Trade With Attractive Potential - May 29th, 2022 6:15 pm